Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AbilityOne To Double Rehabilitation Sales To $200 Mil. With S&N Rehab Unit

This article was originally published in The Gray Sheet

Executive Summary

Smith & Nephew will retain a 21.5% equity interest in AbilityOne, which acquired S&N's rehabilitation business for $123 mil. in a deal announced March 27

You may also be interested in...



Dental Distributor Enters Rehab With AbilityOne, Boosts Territorial Sales Reps

Patterson Dental will retain AbilityOne's management team and physical therapy sales force upon closing a $575 mil. purchase of the privately held rehab business by Oct. 25

Dental Distributor Enters Rehab With AbilityOne, Boosts Territorial Sales Reps

Patterson Dental will retain AbilityOne's management team and physical therapy sales force upon closing a $575 mil. purchase of the privately held rehab business by Oct. 25

ATS Gives Smith & Nephew Second Skin; Wound Treatment Portfolio Elevated

Smith & Nephew's joint venture with Advanced Tissue Sciences to develop and market Dermagraft bio-engineered skin will be a major driver of S&N growth over the next five years, the British firm anticipates

Related Content

UsernamePublicRestriction

Register

OM002075

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel